![John B. Hawken](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John B. Hawken
Algemeen Directeur bij Immutep SAS
Actieve functies van John B. Hawken
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Immutep SAS
![]() Immutep SAS Pharmaceuticals: MajorHealth Technology Immutep SAS specializes in biotechnology research and development. It develops immunotherapy treatments for cancer and autoimmune diseases. The company was founded by Frédéric Triebel on October 17, 2001 and is headquartered Orsay, France. | Algemeen Directeur | 02-12-2003 | - |
Voorzitter | 02-12-2003 | 10-04-2010 |
Loopbaan van John B. Hawken
Eerdere bekende functies van John B. Hawken
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Aptanomics SA
![]() Aptanomics SA Pharmaceuticals: MajorHealth Technology Aptanomics SA discovers and develops new drugs in major markets of unmet medical need. Its proprietary discovery engine, based on peptide aptamers, delivers a regular flow of new hits against relevant industrial targets. Aptanomics offers opportunities for drug discovery collaborations leveraging the peptide aptamer technology to identify new druggable sites and screen for small molecule hits. The company was founded by Roger Brent, Pierre Colas and Johm B. Hawken in 2001 and is headquarters in Lyon, France | Corporate Officer/Principal | - | - |
Opleiding van John B. Hawken
University of Oxford | Undergraduate Degree |
INSEAD | Masters Business Admin |
Statistieken
Internationaal
Frankrijk | 4 |
Verenigd Koninkrijk | 2 |
Operationeel
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Chief Executive Officer | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Immutep SAS
![]() Immutep SAS Pharmaceuticals: MajorHealth Technology Immutep SAS specializes in biotechnology research and development. It develops immunotherapy treatments for cancer and autoimmune diseases. The company was founded by Frédéric Triebel on October 17, 2001 and is headquartered Orsay, France. | Health Technology |
Aptanomics SA
![]() Aptanomics SA Pharmaceuticals: MajorHealth Technology Aptanomics SA discovers and develops new drugs in major markets of unmet medical need. Its proprietary discovery engine, based on peptide aptamers, delivers a regular flow of new hits against relevant industrial targets. Aptanomics offers opportunities for drug discovery collaborations leveraging the peptide aptamer technology to identify new druggable sites and screen for small molecule hits. The company was founded by Roger Brent, Pierre Colas and Johm B. Hawken in 2001 and is headquarters in Lyon, France | Health Technology |
- Beurs
- Insiders
- John B. Hawken
- Ervaring